Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CYCLOPHOSPHAMIDE FOR , USP for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where CYCLOPHOSPHAMIDE FOR , USP was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for CYCLOPHOSPHAMIDE FOR , USP

Side Effect Reports % Deaths Hosp.
Death 73 20.1% 73 1
Neoplasm progression 62 17.1% 62 0
Disease progression 39 10.7% 6 0
Neutropenia 32 8.8% 21 0
Thrombocytopenia 23 6.3% 22 0
Exposure during pregnancy 21 5.8% 0 0
Acute graft versus host disease 20 5.5% 0 0
Leukaemia recurrent 18 5.0% 18 0
Disease recurrence 16 4.4% 13 0
No adverse event 15 4.1% 0 0
Liver function test abnormal 7 1.9% 0 0
Precursor t-lymphoblastic lymphoma/leukaemia recurrent 6 1.7% 0 0
Bacteraemia 5 1.4% 0 0
Chronic graft versus host disease 5 1.4% 0 0
Dehydration 5 1.4% 0 4

Other Indications for CYCLOPHOSPHAMIDE FOR , USP

Breast cancer (98) Acute leukaemia (25) Prophylaxis against graft versus host disease (25) Blast crisis in myelogenous leukaemia (21) Mantle cell lymphoma (21) Leukaemia (18) B-cell lymphoma (15) Plasma cell myeloma (14) Acute lymphocytic leukaemia (12) Myelodysplastic syndrome (12)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

CYCLOPHOSPHAMIDE FOR , USP Full Profile All Diffuse large b-cell lymphoma Drugs CYCLOPHOSPHAMIDE FOR , USP Demographics CYCLOPHOSPHAMIDE FOR , USP Timeline